Pressmeddelande -

Biosensor- Attana Cell 200, label free, real time kinetics on cells



Attana AB introduces the Attana Cell 200 – the first system to permit real-time kinetic analysis of molecular interactions directly on cell surfaces, bringing drug development a step closer to the body.


As the first company in the world, Attana launches a system measuring molecular interactions label free directly on cell surfaces. In line with Attana’s innovative strategy, the Attana Cell 200 is a revolutionary system that rapidly generates biologically relevant information on molecular interactions with cell surfaces. Thanks to groundbreaking innovations and sedulous developments, Attana is the only player on the market that offers cells integrated as sensor surface. The experiments mimic real life conditions and generate information with higher biological relevance in comparison with traditional synthetic sensor surfaces.

Drug development is financially risky and time consuming. To save money and time the industry needs to early identify and eliminate unsuitable candidates. Attana Cell 200 biosensor system improves the selection process by rapidly identifying promising drug candidates. This enables early and well informed decisions in selecting relevant candidates while reducing unnecessary development costs and saving time. The Attana Cell 200 is label free, can run unpurified candidate molecules and has high throughput, resulting in fast and efficient screening of many drug candidates.

Attana Cell 200 is launched with new applications such as kinetic evaluation of cellular biomolecular interactions, e.g. antibody-receptor and lectin-carbohydrate, competition assays and cell capturing.

For more information, please contact Gabriela Suhoschi, Marketing Manager, Attana AB: gabriela.suhoschi@attana.com, +46 (0) 8- 674 57 12 or visit our web:www.attana.com

For press release in Swedish please see attached document.

Ämnen

  • Vetenskap, teknik

Kategorier

  • biosensor
  • kinetics on cells
  • cell
  • attana cell 200
  • attana
  • qcm
  • quartz crystal microbalance
  • biosensors
  • biotech
  • lectin

About Attana AB

Based in Stockholm, Sweden, Attana AB develops and sells biosensors for analysis of biomolecular interactions. Our systems have since 2003 been employed at leading life science companies and universities worldwide, working in a wide variety of research fields. Attana’s biosensors can be used to determine specificity, kinetics and affinity, amongst other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.

Relaterat innehåll

Attana uppmärksammades i USA med Today in America

3 mars 2011, Stockholm, Sverige –Biosensorföretaget Attana AB är med i nationell TV i USA, på CNN och FOX i programmet Today in America with Terry Bradshaw. Attanas nyaste produkt, Attana Cell 200 biosensorn ger information med hög biologisk relevans - data om interaktioner mellan molekyler på ett sätt som efterliknar kroppens miljö och därmed bidrar till effektivare utveckling av nya läkemedel.

Attana highlighted in Today in America with Terry Bradshaw

March 3rd, 2011, Stockholm, Sweden – Attana AB, developer of biosensors, is proud to announce our participation in Today in America with Terry Bradshaw in their series on topics, trends, and issues related to “Improving Diagnostic Outcomes through Biosensor Technology” as part of the show’s “Medical Minutes” series.

PEGS 2010 with Attana!

We are happy to have met so many industry people during the Protein Engineering Summit 2010 in Boston last week, and if you were there but didn't get the chance to taste our exquisite espresso you are welcome to stop by our booth during our upcoming events!

German inauguration with Attana 200 biosensor!

Attana appears in Dresdner Neueste Nachrichten, a regional German newspaper in association with the inauguration of the new “B CUBE” research labs of the Technische Universität Dresden. The new research labs are part of a large regional German investment for scientific research and innovative technologies. The Attana 200 appears here as one of B CUBE’s innovative biosensor technologies.

PEGS 2011 with Attana!

We are pleased to have met so many like minded members of industry during the Protein Engineering Summit 2011 in Boston last week. If you were there but didn't get the chance to taste our exquisite espresso you are always welcome to stop by our booth during our upcoming events!

Tecan Journal- corporate news!

Find out latest news, events and collaborations from Tecan- read the interview with Attana's Sales and Marketing Manager, Gabriela Suhoschi about Attana's collaboration with Tecan's on page 5!

Find out: Why bridge the existing gap between biochemical and cell based assays?

One efficient tool in the selection process is biochemical label‐free kinetic characterisation of interactions between candidate and target molecules. Information on association and dissociation rates and affinity is provided under purified conditions. However, the results obtained are often different compared to the affinity results obtained with cell based methods.

En ny Generation av Cell-Biosensorer för cancer-forskning

Läs artikeln i det senaste numret av  IPT (Innovations in Pharmaceutical technologies) om nya generationens cell-biosensorer som möjliggör studier  av molekylära interaktioner direkt på celler och på så sätt indikerar rätt läkemedelskandidater i ett tidigare skede inför bland annat cancer-forskning. Att få fram en bra biologiskt anpassad modell som denna med hjälp av en cell-biosensor minskar kost

Biotech companies - Ways to work more efficiently

Ernst & Young recently released their 24th annual report Beyond borders: global biotechnology report 2010, presenting, among other things, five guiding principles for biotech companies working in the new economy where funding is scarce and customers careful:
Seizing funding opportunities. Companies need to broaden the search for capital to include nontraditional (and non-dilutive) sourc

Universities and Innovation

We consider it strategically important to keep collaborating with our customers, university researchers in particular, to stay on top and keep getting inspired.

A film crew, cameras and biosensors!

Recently a film crew visited the Attana office to prepare our participation on Terry Bradshaw’s “Today in America” show. Their research team had heard about our ground breaking cell based biosensor and asked us to participate on the show. The days before the filming were filled with intense preparation, and consequently on the day of shooting everything went smoothly.

Relaterade event

Attana at Discovery Summit 2010

Tid 24 Februari 2010

Plats Majestic Barrière Hotel | Cannes | France http://www.discovery-summit.com/

Attana at PEGS 2010- the essential protein engineering summit

Tid 17 Maj 2010 – 21 Maj 2010

Plats Sheraton Boston Hotel, Boston Massachusetts

Attana at PEGS 2010- the essential protein engineering summit

Tid 17 Maj 2010 08:00 – 21 Maj 2010 11:00

Plats Sheraton Boston Hotel, Boston Massachusetts

Kinetics on cells - Come see Attana at PEGS!

Tid 4 Maj 2010 – 21 Maj 2010

Plats Sheraton Hotel in Boston Massachusetts USA

Evaluating Novel Technologies for Cell Based Screening

Tid 15 Juni 2010 – 16 Juni 2010

Plats Sheraton Philadelphia City Center - USA

Next Generation Protein Therapeutics

Tid 28 September 2010 – 29 September 2010

Plats Sheraton Brussels Hotel Brussels, Belgium

Attana Kinetics on Cells Course!

Tid 26 Oktober 2011 – 27 Oktober 2011

Plats Stockholm, Sweden

Attana at PepTalk

Tid 10 Januari 2011 – 14 Januari 2011

Plats Hotel Del Coronado, San Diego, USA

Attana at Antibody Engineering & Design

Tid 22 Februari 2011 – 24 Februari 2011

Plats InterCity Hotel, Frankfurt

SBS 17th Annual Conference and Exhibition

Tid 27 Mars 2011 – 31 Mars 2011

Plats Orlando, Florida, US

International Congress of Antibodies (ICA 2011)

Tid 23 Mars 2011 – 25 Mars 2011

Plats Beijing, China

International Drug Discovery Science and Technology- BIT’s 9th Annual Congress

Tid 3 November 2011 09:00 – 6 November 2011 17:00

Plats Shenzhen Convention and Exhibit Center, China

Advances in the Applications of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells

Tid 25 Juni 2012 09:00 – 27 Juni 2012 17:00

Plats Santa Marina Hotel, Mykonos, Greece